Double J Stent Clinical Trial
— IJJOfficial title:
Incidence and Factors Associated With Double-J Urinary Stent Infection (IJJ)
| Verified date | February 2019 |
| Source | Centre Hospitalier Universitaire de Besancon |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
The aim of the study was to determine the incidence and factors associated with double-J urinary stent infection.
| Status | Not yet recruiting |
| Enrollment | 800 |
| Est. completion date | December 2021 |
| Est. primary completion date | April 2021 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - Patients with a double-J stent placement or change in the hospital Exclusion Criteria: - renal transplants less than one year old |
| Country | Name | City | State |
|---|---|---|---|
| France | CHU de Besançon | Besançon |
| Lead Sponsor | Collaborator |
|---|---|
| Centre Hospitalier Universitaire de Besancon |
France,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Number of patients with urinary tract infection associated with double J stent | Number of patients with urinary tract infection associated with double J stent | 6 months | |
| Primary | Number of patients with specific clinical data associated with urinary tract infection associated with double J stent | Clinical data (Age, sex, gender, comorbidities, indication of procedure, duration of double J stent placement) will be compared between patient with urinary tract infection and no urinary tract infection associated with double J stent | 6 months | |
| Secondary | Number of patients with relapse and/or recurrence after a first urinary tract infection | Number of patients with relapse and/or recurrence after a first urinary tract infection | 6 months |